FindTrial
Sign In

Taxane Chemotherapy

DRUG5 trials

Sponsors

University of Florida, Azienda Ospedaliero-Universitaria Careggi, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Shanghai Jiao Tong University School of Medicine

Conditions

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Elderly PatientsHER2 + Breast CancerHR Positive/HER2 Low Breast CancerMetastatic Prostate Cancer

Phase 1

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
WithdrawnNCT03611985
University of FloridaBreast Cancer
Start: 2020-03-31End: 2023-03-31Updated: 2020-01-13
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
RecruitingNCT05074290
University of FloridaBreast Cancer
Start: 2023-03-30End: 2026-12-01Target: 74Updated: 2026-02-17

Phase 2

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
Not yet recruitingNCT07317778
Cancer Institute and Hospital, Chinese Academy of Medical SciencesBreast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer
Start: 2026-02-15End: 2033-09-15Target: 249Updated: 2026-01-05
Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer
RecruitingNCT07393425
Shanghai Jiao Tong University School of MedicineHER2 + Breast Cancer
Start: 2026-02-02End: 2032-09-30Target: 50Updated: 2026-02-06

Unknown Phase

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer
CompletedNCT05471427
Azienda Ospedaliero-Universitaria CareggiElderly Patients, Metastatic Prostate Cancer
Start: 2020-01-01End: 2022-07-01Updated: 2022-07-22

Related Papers

Abstract P3-12-17: NCT05074290 Phase I/II study of Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
Clinical Cancer Research2025-06-13